Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 Dec;40(12):1361–1370. doi: 10.1136/hrt.40.12.1361

Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.

G G Turner, R R Nelson, L A Nordstrom, H C Diefenthal, F L Gobel
PMCID: PMC483580  PMID: 32899

Full text

PDF
1361

Images in this article

1364Image
on p.1364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman E. L., Davies R. O., Crowley J. J., Lopes M. G., Brooker J. Z., Friedman J. P., Graham A. F., Matlof H. J., Harrison D. C. Dose response effectiveness of propranolol for the treatment of angina pectoris. Circulation. 1975 Jun;51(6):964–975. doi: 10.1161/01.cir.51.6.964. [DOI] [PubMed] [Google Scholar]
  2. Bass H. The flow volume loop: normal standards and abnormalities in chronic obstructive pulmonary disease. Chest. 1973 Feb;63(2):171–176. doi: 10.1378/chest.63.2.171. [DOI] [PubMed] [Google Scholar]
  3. Bruce R. A., Hornsten T. R. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 1969 Mar;11(5):371–390. doi: 10.1016/0033-0620(69)90027-9. [DOI] [PubMed] [Google Scholar]
  4. Feigenbaum H., Popp R. L., Wolfe S. B., Troy B. L., Pombo J. F., Haine C. L., Dodge H. T. Ultrasound measurements of the left ventricle. A correlative study with angiocardiography. Arch Intern Med. 1972 Mar;129(3):461–467. [PubMed] [Google Scholar]
  5. Fortun N. J., Hood W. P., Jr, Sherman M. E., Craige E. Determination of left ventricular volumes by ultrasound. Circulation. 1971 Oct;44(4):575–584. doi: 10.1161/01.cir.44.4.575. [DOI] [PubMed] [Google Scholar]
  6. Frankl W. S., Smith W. K., Rose F. D., MacMillan R., Gomez R., Harkins M. Experience with a multicenter study in the evaluation of propranolol as an effective antianginal agent. J Clin Pharmacol. 1974 Jan;14(1):13–16. doi: 10.1002/j.1552-4604.1974.tb02281.x. [DOI] [PubMed] [Google Scholar]
  7. Frishman W., Smithen C., Befler B., Kligfield P., Killip T. Noninvasive assessment of clinical response to oral propranolol therapy. Am J Cardiol. 1975 May;35(5):635–644. doi: 10.1016/0002-9149(75)90049-1. [DOI] [PubMed] [Google Scholar]
  8. Gobel F. L., Norstrom L. A., Nelson R. R., Jorgensen C. R., Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978 Mar;57(3):549–556. doi: 10.1161/01.cir.57.3.549. [DOI] [PubMed] [Google Scholar]
  9. Gobel F. L. Role and rationale of the use of propranolol in the treatment of patients with angina pectoris. Minn Med. 1976 Sep;59(9):601–607. [PubMed] [Google Scholar]
  10. Hartman K. E., Nordstrom L. A., Gobel F. L. Effect of placebo on exercise response and nitroglycerin consumption. Minn Med. 1976 Dec;59(12):839–843. [PubMed] [Google Scholar]
  11. Henry W. L., Clark C. E., Epstein S. E. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation. 1973 Feb;47(2):225–233. doi: 10.1161/01.cir.47.2.225. [DOI] [PubMed] [Google Scholar]
  12. Johnson M. L. Echocardiographic evaluation of left ventricular size and function and function and its application in coronary artery disese. Adv Cardiol. 1976;17:105–122. doi: 10.1159/000398832. [DOI] [PubMed] [Google Scholar]
  13. Lee R. J., Evans D. B., Baky S. H., Laffan R. J. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol. 1975 Sep-Oct;33(2):371–382. doi: 10.1016/0014-2999(75)90182-x. [DOI] [PubMed] [Google Scholar]
  14. Macdonald A. G., Ingram C. G., McNeill R. S. The effect of propranolol on airway resistance. Br J Anaesth. 1967 Dec;39(12):919–926. doi: 10.1093/bja/39.12.919. [DOI] [PubMed] [Google Scholar]
  15. Miller R. R., Olson H. G., Pratt C. M., Amsterdam E. Z., Mason D. T. Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):598–605. doi: 10.1002/cpt1975185part1598. [DOI] [PubMed] [Google Scholar]
  16. Nordstrom L. A., MacDonald F., Gobel F. L. Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease. Chest. 1975 Mar;67(3):287–292. doi: 10.1378/chest.67.3.287. [DOI] [PubMed] [Google Scholar]
  17. Pombo J. F., Troy B. L., Russell R. O., Jr Left ventricular volumes and ejection fraction by echocardiography. Circulation. 1971 Apr;43(4):480–490. doi: 10.1161/01.cir.43.4.480. [DOI] [PubMed] [Google Scholar]
  18. Smokler P. E., MacAlpin R. N., Alvaro A., Kattus A. A. Reproducibility of a multi-stage near maximal treadmill test for exercise tolerance in angina pectoris. Circulation. 1973 Aug;48(2):346–351. doi: 10.1161/01.cir.48.2.346. [DOI] [PubMed] [Google Scholar]
  19. Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
  20. Teichholz L. E., Kreulen T., Herman M. V., Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976 Jan;37(1):7–11. doi: 10.1016/0002-9149(76)90491-4. [DOI] [PubMed] [Google Scholar]
  21. Weissler A. M., Harris W. S., Schoenfeld C. D. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol. 1969 Apr;23(4):577–583. doi: 10.1016/0002-9149(69)90012-5. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES